PRC2
终端(电信)
EZH2型
细胞生物学
领域(数学分析)
化学
生物
遗传学
计算机科学
染色质
计算机网络
DNA
数学
数学分析
作者
Agata L. Patriotis,Yadira M. Soto-Feliciano,Douglas Barrows,Laiba F Khan,Marylène Leboeuf,Peder J. Lund,Matthew R. Marunde,Annaelle M. Djomo,Michael‐Christopher Keogh,Thomas S. Carroll,Benjamin A. García,Alexey A. Soshnev,C. David Allis
标识
DOI:10.1101/2025.02.04.636462
摘要
Abstract Polycomb group proteins maintain gene expression patterns established during early development, with Polycomb Repressive Complex 2 (PRC2) methyltransferase a key regulator of cell differentiation, identity and plasticity. Consequently, extensive somatic mutations in PRC2, including gain- or loss- of function (GOF or LOF), are observed in human cancers. The regulation of chromatin structure by PRC2 is critically dependent on its EZH2 (Enhancer of Zeste Homolog 2) subunit, which catalyzes the methylation of histone H3 lysine 27 (H3K27). Recent structural studies of PRC2 revealed extensive conformational changes in the non-catalytic EZH2 N-terminal SANT-Binding Domain (SBD) during PRC2 activation, though the functional significance remains unclear. Here, we investigate how the SBD regulates PRC2 function. The domain is highly conserved in metazoans, dispensable for PRC2 assembly and chromatin localization, yet required for genome-wide histone H3K27 methylation. Further, we show that an intact SBD is necessary for the proliferation of EZH2- addicted lymphomas, and its deletion in the presence of EZH2 GOF mutations inhibits cancer cell growth. These observations provide new insights to the regulation of PRC2 activity in normal development and malignancy.
科研通智能强力驱动
Strongly Powered by AbleSci AI